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Abstract
Background: Although the iceA (induced by contact with epithelium) allelic types of Helicobacter pylori have been reported
to be associated with peptic ulcer, the importance of iceA on clinical outcomes based on subsequent studies is
controversial. The aim of this study was to estimate the magnitude of the risk for clinical outcomes associated with
iceA.
Methods: A literature search was performed using the PubMed and EMBASE databases for articles published through April
2011. Published case-control studies examining the relationship between iceA and clinical outcomes (gastritis, peptic ulcer,
including gastric ulcer and duodenal ulcer, and gastric cancer) were included.
Results: Fifty studies with a total of 5,357 patients were identified in the search. Infection with iceA1-positive H. pylori
increased the overall risk for peptic ulcer by 1.26-fold (95% confidence interval [CI], 1.09–1.45). However, the test for
heterogeneity was significant among these studies. Sensitivity analysis showed that the presence of iceA1 was significantly
associated with peptic ulcer (odds ratio [OR]=1.25, 95% CI=1.08–1.44). The presence of iceA2 was inversely associated with
peptic ulcer (OR=0.76, 95% CI=0.65–0.89). The presence of iceA was not associated with gastric cancer. Most studies
examined the cagA status; however, only 15 studies examined the correlation and only 2 showed a positive correlation
between the presence of cagA and iceA1.
Conclusion: Our meta-analysis confirmed the importance of the presence of iceA for peptic ulcer, although the significance
was marginal.
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Introduction
Helicobacter pylori infection is now accepted as the major cause of
chronic gastritis. Several epidemiological studies have shown that
H. pylori infection is also linked to severe gastritis-associated
diseases, including peptic ulcer disease (PUD) and gastric cancer
(GC) [1]. In 1994, the International Agency for Research on
Cancer categorized H. pylori infection as a group I carcinogen
(definite carcinogen) [2]. The infection remains latent in the
majority of infected patients, with only approximately 20% of
infected individuals developing severe diseases. In addition to host,
environmental, and dietary factors, another possible reason for the
various outcomes of H. pylori infection relates to differences in the
virulence of H. pylori strains. Several H. pylori virulence factors have
been reported to be associated with peptic ulcer and GC, including
cagA, vacA, babA, and oipA [1,3–6]. We recently reported the
importance of the duodenal ulcer-promoting gene (dupA) for
developing duodenal ulcer (DU) in a meta-analysis model [7].
An initial series of studies showed that iceA (induced by contact
with epithelium) has 2 main allelic variants, iceA1 and iceA2 [8,9].
iceA1 demonstrated sequence homology with a gene from Neisseria
lactamica, nlaIIIR, which encodes a CTAG-specific restriction
endonuclease [9]. On the other hand, iceA2 has no homology to
known genes and the function of the iceA2 product remains
unclear. van Doorn et al. reported that the iceA allelic type was
independent of the cagA and vacA status, and there was a significant
association between the presence of the iceA1 allele and PUD [8].
The expression of iceA1 was upregulated on contact between H.
pylori and human epithelial cells, and the iceA1 genotype was linked
with enhanced mucosal interleukin (IL)-8 expression and acute
antral inflammation [9,10].
However, the role of iceA was controversial subsequently since
several studies were not able to reproduce the observation in other
populations, including Japanese [11–15]. Such discrepant results
between the iceA allelic type and clinical outcomes could be
explained by the genetic heterogeneity or differences in the
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virulence genes [16]. So far, there is no report on the significance
of iceA using meta-analysis. In this study, we aimed to perform a
meta-analysis to examine the relationship between the iceA allelic
type and clinical outcomes.
Materials and Methods
A literature search was performed using the PubMed and
EMBASE databases for articles published through April 2011.
The following text words were used: 1) iceA, iceA1,o riceA2 and 2)
pylori or Helicobacter. We did not include abstracts alone or
unpublished articles.
Inclusion Criteria
The following criteria were applied to select fully published case-
control studies examining the relationship between the iceA type and
clinical outcomes (gastritis, PUD, gastric ulcer [GU], DU, and GC)
in adult populations: the presence of iceA (iceA1 or iceA2) was
examined by polymerase chain reaction (PCR) and original articles
were published in English. Studies were excluded if no raw data
were presented. When it appeared that the same subjects were
presented in multiple reports, the earliest article was selected. All
potentially relevant articles were reviewed independently by 2
investigators (S.S and Y.Y) and disagreement was resolved by
discussion.
Exclusion Criteria
Studies were excluded if no raw data were presented or if no
control groups were included. In addition, in vitro studies and
studies conducted in child populations were also excluded.
Data Extraction
Data were extracted independently from each study by the
investigators and entered into a computerized database. The
information retrieved covered countries where the study was
performed, characteristics of cases and controls, the method for
detection of iceA, the number of subjects, and the iceA status
according to clinical outcomes. Two studies examined the
prevalence of iceA in several countries [6,11]; thus, the data of each
country were entered in separate sheets as an independent study.
Statistical analysis
Summary odds ratios (ORs) and 95% confidence intervals (CIs)
were calculated from raw data. The Mantel-Haenszel method was
used to test for statistical heterogeneity. When statistical
heterogeneity was noted, the proportion of the total heterogeneity
variance was calculated from each study using a fixed-effects
model to guide the search for sources of methodologically and
clinically important variables. To exclude any possible influence of
a single study, we performed a sensitivity analysis to evaluate
whether the exclusion of any single study substantially altered the
magnitude or statistical result of the summary estimate. Publica-
tion bias was assessed by funnel plots and regression test by Egger
et al [17]. A P value of ,0.05 was considered as statistically
significant. All analyses were performed using Comprehensive
Meta-Analysis software (version 2, Biostat, Englewood, NJ).
Results
The literature searches generated 140 potentially relevant
citations. Of these, 93 articles were excluded. The main reasons
for exclusion were that the articles were review articles, not
case-control studies, conducted in children, and in vitro studies.
Therefore, 46 articles met the inclusion criteria (Figure S1 and
Table S1). Two articles included several countries (4 in Yamaoka
et al.[11] and 2 in Yamaoka et al. [6]). For these studies, data from
different countries in the same article were considered as separate
studies (data); therefore, 50 studies with a total of 5,357 patients
met the inclusion criteria. Among these studies, 28 were from
Asian [11–15,18–39], 19 from Western [6,8,9,11,40–52], and 3
from African countries [53–55]. An age- and sex-matched case-
control study was conducted in only 1 report [47]. Although 46
articles showed a difference in the iceA type between gastritis and
PUD, 14 articles did not show the distribution of GU and DU
[12,18–20,24,28,32,36,39,43,48,52,53,55]. Four studies examined
the prevalence of iceA types in gastritis and GC, but not in PUD
[13,26,44,51]. Six studies examined only the prevalence of iceA1
but not iceA2 [6,13,20,22,41]. The prevalence of mixed infection
by iceA1 and iceA2 was also different in each study; it ranged from
1.9% [14] to 36.7% [40]. Overall, the rate of mixed infection was
13.9%. Although strains from mixed infections were excluded in
several studies [23,29,43,46,49], most studies included these mixed
genotypes as total denominator. In this study, iceA1-positive means
only iceA1-positive cases, but not iceA1- and iceA2-positive.
Likewise, iceA2-positive means only iceA2-positive cases, but not
iceA1- and iceA2-positive.
Association between the iceA1 status and clinical
outcomes
The prevalence of iceA1 in PUD patients was examined in 46
studies from 24 countries. The prevalence of iceA1 ranged from
0.0% to 100.0% in PUD patients and from 4.3% to 100.0% in
controls. Among 46 studies, a significantly higher prevalence of
iceA1 in PUD compared with controls was found in 4 studies
[9,32,35,47]. Only 1 study showed a significantly lower prevalence
of iceA1 in PUD patients compared with controls [11]. The overall
prevalence of iceA1 was 59.3% (1,264 of 2,131) in PUD patients
and 51.0% (1,260 of 2,470) in controls. The summary OR in the
fixed-effects model was 1.26 (95% CI, 1.09–1.45). However, the
test for heterogeneity was significant among these studies (I
squared = 35.5, P=0.01), suggesting the existence of either
methodological or clinical heterogeneity. By exploring the sources
of heterogeneity, we found that the studies by Peek et al.[9] and
Momenah et al. [32] showed larger differences in the prevalence of
iceA1 compared with other studies. They reported a quite low
prevalence of iceA1 in controls (4.3% and 5.4%, respectively)
compared with PUD patients (47.6% and 100%, respectively).
In addition, the study by Yamaoka et al. in the United States
showed a lower prevalence of iceA1, especially in PUD patients
(0.0%) [11]. The study by Gatti et al. showed 100% prevalence in
controls [49]. Sensitivity analysis excluding these 4 studies showed
a similar OR (1.25; 95% CI, 1.08–1.44) and the test for
heterogeneity was no longer statistically significant (I squared =
4.5, P=0.38) (Figure 1). Publication bias did not exist (intercept =
0.17; P=0.36).
Subgroup analysis by 2 areas (Asian or Western countries) was
also performed. The prevalence of iceA1 was 68.9% (840 of 1,218)
in PUD patients and 58.1% (676 of 1,163) in controls in Asian
countries. It was 43.5% (348 of 799) in PUD patients and 41.8%
(447 of 1,068) in controls in Western countries. The summary OR
was 1.19 (95% CI, 0.97–1.45) in Asian countries and 1.28 (95%
CI, 1.02–1.61) in Western countries. Subgroup analysis was also
performed according to the distribution of DU and GU. The
prevalence of iceA1 in DU patients was examined in 32 studies.
When 4 studies [9,11,32,49] of larger effect size were excluded
to limit heterogeneity, iceA1 was significantly associated with
DU compared with controls (OR=1.35, 95% CI=1.11–1.63)
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(OR=1.38, 95% CI=1.06–1.79). The prevalence of iceA1 was
examined in GU patients from 15 studies. One study included only
1 patient with GU [9]; therefore, this study was excluded from the
statistical analysis. There was no association between iceA1 and GU
compared with controls (OR=0.96, 95% CI=0.69–1.35) (Figure
S3). The prevalence of iceA1 was examined in GC patients from 23
studies. One study included only 1 patient with GC [9]; therefore,
this study was excluded from the statistical analysis. There was no
association between iceA1 and GC compared with controls
(OR=1.08, 95% CI=0.86–1.37) (Figure S4).
Association between the iceA2 status and clinical
outcomes
The prevalence of iceA2 was examined in PUD patients from 41
studies (24 countries). The prevalence of iceA2 ranged from 0.0%
to 91.7% in PUD patients and from 0.0% to 95.7% in controls.
Among the 41 studies, a significantly lower prevalence of iceA2 in
PUD patients compared with controls was found in 6 studies
[8,9,32,35,47,52]. The overall prevalence of iceA2 was 30.1% (585
of 1,944) in PUD patients and 37.2% (841 of 2,261) in controls.
The summary OR in the fixed-effects model was 0.76 (95% CI,
0.65–0.89). However, the test for heterogeneity was significant
Figure 1. Results of the meta-analysis for the risk of peptic ulcer in iceA1-positive H. pylori infections. Odds ratios (ORs) and their 95%
confidence intervals (CI) in summary and for each study are presented using a fixed-effect model. PUD: peptic ulcer disease.
doi:10.1371/journal.pone.0030354.g001
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Peek et al.[9] and Momenah et al. [32] showed larger differences in
the prevalence of iceA2 compared with other studies. They
reported a quiet high prevalence of iceA2 in controls (95.7% and
94.6%, respectively) compared with PUD patients (47.6% and
0.0%, respectively). In addition, the study by Yamaoka et al. in
Korea showed a lower prevalence of iceA2, especially in gastritis
patients (4.5%) [11]. The study by Gatti et al. showed 0.0%
prevalence in controls [49]. Sensitivity analysis excluding these 4
studies showed a similar OR (0.78; 95% CI, 0.66–0.91) and the
test for heterogeneity was no longer statistically significant (I
squared = 19.9, P=0.14) (Figure 2). Publication bias did not exist
(intercept, 0.35; P=0.27).
Subgroup analysis by 2 areas (Asian or Western countries) was
also performed. The prevalence of iceA2 was 23.4% (269 of 1,148)
in PUD patients and 30.2% (318 of 1,051) in controls in Asian
countries. It was 41.8% (280 of 669) in PUD patients and 47.7%
(456 of 956) in controls in Western countries. The summary OR
was 0.91 (95% CI, 0.73–1.13) in Asian countries and 0.64 (95%
CI, 0.50–0.82) in Western countries. Subgroup analysis was
performed according to the distribution of DU and GU. The
prevalence of iceA2 in DU patients was examined in 27 studies.
When 4 studies [9,11,32,49] of larger effect size were excluded to
limit heterogeneity, iceA2 was significantly associated with DU
compared with controls (OR=0.76, 95% CI=0.60- 0.92) (Figure
S5). This finding was significant in Western countries (OR=0.66,
95% CI=0.48–0.91). The prevalence of iceA2 was examined in
GU patients from 13 studies. There was no association between
iceA2 and GU compared with controls (OR=1.01, 95%
CI=0.69–1.46) (Figure S6). The prevalence of iceA2 was examined
Figure 2. Results of the meta-analysis for the risk of peptic ulcer in iceA2-positive H. pylori infections.
doi:10.1371/journal.pone.0030354.g002
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with GC [9]; therefore, this study was excluded from the statistical
analysis. There was no association between iceA2 and GC
compared with controls (OR=0.84, 95% CI=064–1.11) (Figure
S7). Subgroup analysis according to the area showed that the OR
was 1.10 (95% CI, 0.72–1.67) in Asian countries and 0.70 (95%
CI, 0.49–1.00) in Western countries.
Difference in prevalence in Asian and Western countries
The overall prevalence of iceA1 was 64.6% (1,791 of 2,771) in
Asian countries and 42.1% (935 of 2,218) in Western countries. It
was significantly higher in Asian countries than in Western
countries (P,0.0001). On the other hand, the prevalence of iceA2
was 25.8% (651 of 2,522) in Asian countries and 45.1% (844 of
1,871) in Western countries. It was significantly higher in Western
countries than in Asian countries (P,0.0001).
Correlation between cagA and iceA
Fifteen studies examined the correlation between the cagA and
iceA status. Only 1 study showed a significant positive association
between iceA1 and the presence of cagA [41]. One study showed a
positive trend [9]. Another study showed a significant positive
association between iceA2 and the presence of cagA [42]. Twelve
studies showed no association between iceA1 and cagA status
[8,11,19–21,31,36,49,52].
Discussion
Our present meta-analysis shows that the presence of iceA1 was
significantly associated with PUD. Although several studies failed
to show a positive association between the iceA status and clinical
outcomes, this meta-analysis supported the original report from
1998 [9]. However, this association was not very strong.
The mechanism of the development of PUD induced by iceA
remains unclear. iceA1 demonstrated sequence homology with a
gene from Neisseria lactamica, nlaIIIR, which encodes a CTAG-
specific restriction endonuclease [9]. However, studies on the
genetic organization of the iceA locus indicated that a full-length
nlaIIIR-like open reading frame has only been observed in 10
(20.4%) of 49 iceA1 H. pylori strains and only full-length iceA1 was a
functional endonuclease gene [10]. These data indicate that
mutations in iceA1 are common, resulting in protein products with
poor or no endonuclease activity. It remains to be determined
whether iceA1 plays a role other than encoding an nlaIII-like
endonuclease or not.
Most isolates with an iceA2 allele could be divided into 2 types
according to the presence of repeated sequences of 105 nucleotides
and the size of the PCR products (229 bp for iceA2-1 or 334 bp for
iceA2-2) [8]. Ashour et al. reported that no association was observed
between the size of the iceA2 amplicon and diseases [42]. On the
other hand, Kidd et al. reported that the 334-bp iceA2 amplicon
was more prevalent in strains from patients with PUD [53]. These
changes may translate into differential binding or function of the
protein. The function of iceA2 remains unclear.
The prevalence of mixed infection by iceA1 and iceA2 was also
different in each study. The strains of mixed infections were
excluded in several studies [23,29,43,46,49]. Figueiredo et al.
reported that 36.7% of strains were positive for both iceA1 and
iceA2, and 53.8% of these strains also contained multiple vacA
genotypes [40]. In our previous study, the rate of both iceA1 and
iceA2 positivity was significantly lower in the United States than in
Korea, Japan, and Columbia (4.3% vs. 20.0, 17.0, and 22.4%,
respectively) [11]. Multiple genotypes indicate the presence of
multiple strains because there is no full-sequenced strain
containing both iceA1 and iceA2 genes in Genbank (data not
shown). It may be speculated that more than 1 strain may be
acquired in childhood, especially in countries with a high
prevalence of H. pylori. Mixed infection by more than 1 strain in
the same individual may reflect the capacity of H. pylori to evolve
genetic variations during long-term colonization from childhood
[56]. The high prevalence of mixed iceA-type strains may obscure
any potential relationship between the allele and clinical outcomes.
Fourteen studies combined DU with GU as PUD. However,
DU and GU are linked to entirely different patterns of gastric
inflammation, such that it would seem they should be examined
separately [6]. Tham et al. indicated that in patients with H. pylori
infection, those with DU have a higher degree of acute and
chronic inflammation in the gastric antrum and higher H. pylori
density than those with GU [57], which illustrates the different
pathogenic processes of DU and GU. Therefore, a study to
examine the roles of virulence factors needs to be conducted
according to DU and GU, respectively. Furthermore, we should
pay attention to the fact that patients with only gastritis at the time
of endoscopy may develop ulcer diseases later in life and,
therefore, may have been misclassified in the present study [8].
The association between the iceA and cagA status remains
unclear. Several virulence factors of H. pylori correlated with the
presence of cagA [6,58,59]. In this study, we found that 15 studies
examined the association between the iceA and cagA status. As a
result, most of them showed no association, indicating that iceA1
might be a risk factor for PUD, independent of cagA. In addition,
our recent meta-analysis showed that dupA, which induces DU and
has a suppressive action on GC, was significantly associated with
DU [7]. The association between dupA and iceA has not been
clarified yet; however, 1 study showed that there was no
association [37]. To confirm the significance of iceA, it is better
to perform a multivariate analysis adjusted for the cagA status and
other risk factors for peptic ulcer. However, unfortunately, we
could not obtain the raw data from each study. It is difficult to
perform a multivariate analysis adjusted for these factors without
the raw data. In addition, most studies did not consider other risk
factors in their papers. Further study is necessary to examine
which factors are true virulence factors and which are just
confounding factors. However, it might be better to hypothesize
that these factors interact synergistically with each other and
induce serious diseases than to discuss which of these factors is the
most virulent. A recent study showed that groupings by multi-locus
sequence typing (MLST) using 7 housekeeping genes were
associated with the prevalence of GC [60], although we reported
a problem of this interpretation [61]. It may be better to classify H.
pylori according to the structure of the bacteria instead of each
virulence factor.
Conclusion
iceA1 was weakly, but significantly associated with PUD
especially DU, whereas iceA2 was inversely associated with PUD.
A relationship between iceA and GC and GU was not found in this
meta-analysis. It is possible that iceA is a discriminating factor for
PUD, independent of cagA.
Supporting Information
Figure S1 Flow diagram of study selection.
(TIF)
Figure S2 Results of the meta-analysis for the risk of duodenal
ulcer in iceA1-positive H. pylori infections.
(TIF)
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ulcer in iceA1-positive H. pylori infections.
(TIF)
Figure S4 Results of the meta-analysis for the risk of gastric
cancer in iceA1-positive H. pylori infections.
(TIF)
Figure S5 Results of the meta-analysis for the risk of duodenal
ulcer in iceA2-positive H. pylori infections.
(TIF)
Figure S6 Results of the meta-analysis for the risk of gastric
ulcer in iceA2-positive H. pylori infections.
(TIF)
Figure S7 Results of the meta-analysis for the risk of gastric
cancer in iceA2-positive H. pylori infections.
(TIF)
Table S1 Characteristics of studies included in the meta-
analysis.
(XLS)
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